// App-Quantinova.ai

21 : Canakinumab use during pregnancy for the treatment of systemic onset juvenile idiopathic arthritis and refractory macrophage activation syndrome

Researchers

Presenter

  • Jessica L Gunn

Principal Investigators

  • Rosemary Waller

  • Lorraine O'Neil

  • Joel David

Medical Centers

  • Rheumatology, Great Western Hospital, Swindon, UNITED KINGDOM

  • Rheumatology, Nuffield Orthopaedic Centre, Oxford, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Macrophage activation syndrome

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • canakinumab (SC)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved